Estònia - estonià - Ravimiamet

sandoz pharmaceuticals d.d. - atomoksetiin - kõvakapsel - 18mg 7tk; 18mg 14tk; 18mg 84tk; 18mg 28tk

Unió Europea - estonià - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - kana - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Estònia - estonià - Ravimiamet

sandoz pharmaceuticals d.d. - etorikoksiib - õhukese polümeerikattega tablett - 120mg 20tk; 120mg 56tk; 120mg 90tk; 120mg 28tk

Estònia - estonià - Ravimiamet

sandoz pharmaceuticals d.d. - etorikoksiib - õhukese polümeerikattega tablett - 30mg 28tk

Estònia - estonià - Ravimiamet

sandoz pharmaceuticals d.d. - etorikoksiib - õhukese polümeerikattega tablett - 60mg 28tk; 60mg 14tk; 60mg 50tk; 60mg 10tk

Estònia - estonià - Ravimiamet

sandoz pharmaceuticals d.d. - etorikoksiib - õhukese polümeerikattega tablett - 90mg 7tk

Unió Europea - estonià - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kana - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Estònia - estonià - Ravimiamet

sandoz pharmaceuticals d.d. - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 30tk

Estònia - estonià - Ravimiamet

sandoz pharmaceuticals d.d. - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 60tk; 1000mg+50mg 30tk

Unió Europea - estonià - EMA (European Medicines Agency)

amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - preparaadid haavade ja haavandite raviks - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.